Skip to content
ALS News Today logo Newsletter
Newsletter
  • About ALS
    What is ALS?
    Causes and risk factors
    Diagnosis
    Symptoms
    • Speech problems
    • Breathing and swallowing
    • Pseudobulbar affect
    Types of ALS
    • Familial ALS
    • Sporadic ALS
    Treatments
    • Approved treatments
    • Experimental treatments
    • Non-drug treatments
  • Living with
    Living with ALS
    Mental health
    Diet
    Exercise
    Aids and adaptations
  • Community
    Columns
    • Joyful Sorrow — Kristin Neva
    • Living Well With ALS — Dagmar Munn
    • Thunder Road — Juliet Taylor
    Archived columns
    • OutSpoken — James Clingman
    • The Mighty Mind — Rachel Doboga
    In memoriam
    • Notes From the ALS Front — Rick Jobus
  • News
  • Forums
  • Resources
    Advocacy partners
  • What can we help you find today?

  • Social Clips
  • A Strong Voice for MND

A Strong Voice for MND

admin avatar

by admin | March 30, 2016

Share this article:

Share article via email
  • Share on Facebook
  • Share on Twitter
  • Share on Reddit
  • Share via Email

In this MND Australia video, “Kirsten Harley speaks about her experience living with motor neurone disease at Parliament House, Canberra, 24 February 2016.”

Learn more about ALS here: https://bit.ly/ALSNewsToday

Print This Page

Tags

patient story

Recent Posts

  • What my journals reveal about my journey as an ALS caregiver
  • Clene, FDA to discuss survival data and approval path for CNM-Au8
  • Managing decision-making fatigue with my ‘two drawers’ method
  • First human trial begins in Europe for ALS, Parkinson’s drug NRG5051
  • ALS gene therapy targeting TDP-43 protein put on FDA fast track


Recommended reading

Speech bubbles show a thumbs-up sign and pages of documents as two people talk during a meeting.
January 15, 2026 News by Marisa Wexler, MS

Clene, FDA to discuss survival data and approval path for CNM-Au8

banner for
January 14, 2026 Columns by Dagmar Munn

Managing decision-making fatigue with my ‘two drawers’ method

An illustration provides a close-up view of mitochondria, the powerhouses of cells.
January 14, 2026 News by Andrea Lobo, PhD

First human trial begins in Europe for ALS, Parkinson’s drug NRG5051

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: [email protected]
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright © 2013-2026 All rights reserved.